Mablink Bioscience
Company
1
follower
Primary tabs
About your organization / profile
Mablink Bioscience is a French-based biotechnology company founded in 2018 developing 3rd generation Antibody-drug Conjugates (ADC) based on proprietary drug-linker technologies.
The founding members gather a unique continuum of skills in chemistry, pharmacology and immunology to develop a hydrophilic easy-to-implement platform for next-generation ADCs.
With our technology platform, we are democratizing the use of ADCs in the clinic to improve patient care in the immuno-oncology field.
Network (0)
There are no organizations in the network.
